Vaccine against scabies: necessity and possibility

Parasitology ◽  
2014 ◽  
Vol 141 (6) ◽  
pp. 725-732 ◽  
Author(s):  
XIAOSONG LIU ◽  
SHELLEY WALTON ◽  
KATE MOUNSEY

SUMMARYScabies is an infectious disease that is endemic in poorly resourced communities, and also common in industrialized countries. Although the disease, which is caused by infestation of Sarcoptes scabiei, is generally mild, the need for a vaccine against S. scabiei is proposed. The immunological mechanisms that control S. scabiei infection are discussed and the current status of scabies vaccine development reviewed. Future directions for scabies vaccine development are also addressed.

Author(s):  
Shih-Bin Su ◽  
Hsiao-Liang Chang ◽  
Kow-Tong Chen

Mumps is an important childhood infectious disease caused by mumps virus (MuV). We reviewed the epidemiology, pathogenesis, and vaccine development of mumps. Previous studies were identified using the key words “mumps” and “epidemiology”, “pathogenesis” or “vaccine” in MEDLINE, PubMed, Embase, Web of Science, and Google Scholar. We excluded the articles that were not published in the English language, manuscripts without abstracts, and opinion articles from the review. The number of cases caused by MuV decreased steeply after the introduction of the mumps vaccine worldwide. In recent years, a global resurgence of mumps cases in developed countries and cases of aseptic meningitis caused by some mumps vaccine strains have renewed the importance of MuV infection worldwide. The performance of mumps vaccination has become an important issue for controlling mumps infections. Vaccine development and routine vaccination are still effective measures to globally reduce the incidence of mumps infections. During outbreaks, a third of MMR vaccine is recommended for groups of persons determined by public authorities.


2020 ◽  
Author(s):  
Xiaolong Cai ◽  
Huajun Bai ◽  
Xiaoyan Zhang

The vaccine helps to provoke the immune system and is an efficacious means for disease prevention and treatment. At this particular time of the COVID-19 outbreak, the vaccine for COVID-19 is urgently needed to save tens of thousands of people’s lives. Here we give some basic information on vaccine classification, generation, and application, and make a brief review on the current status of COVID-19 vaccine and tumor vaccine development both in the clinical trial stage and pre-clinical stage. vaccine


Coronaviruses ◽  
2021 ◽  
Vol 02 ◽  
Author(s):  
Niranjan Kaushik ◽  
Vikram Sharma ◽  
Vikas Sharma

Abstract:: Corona viruses belong to the family Coronaviridae. This pandemic has surprised every human being as many of us facing a pandemic first time in our life. Moreover, absence of a drug or therapy for this disease further aggravates its harmful effects. As a result, world is now preparing to find out a possible therapy against this disease to stop further growth of this pandemic. Some of these therapies include vaccine development, drug development along with possible drugs from natural sources. In this review article, the focus is on current status of research against virus responsible for current pandemic, various mobile apps launched to check spread of viral infection and status of prospective therapies available against this virus.


2016 ◽  
Vol 17 (8) ◽  
pp. 755-762 ◽  
Author(s):  
Xu Zhou ◽  
Renhe Liu ◽  
Shuo Qin ◽  
Ruilian Yu ◽  
Yao Fu

2014 ◽  
Vol 14 (10) ◽  
pp. 903-912 ◽  
Author(s):  
Yeon-Jeong Kim ◽  
Sang-Gu Yeo ◽  
Jae-Hak Park ◽  
Hyun-Jeong Ko

Sign in / Sign up

Export Citation Format

Share Document